2021
DOI: 10.1016/j.comtox.2021.100188
|View full text |Cite
|
Sign up to set email alerts
|

In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

3
5

Authors

Journals

citations
Cited by 18 publications
(9 citation statements)
references
References 181 publications
0
7
0
Order By: Relevance
“…Some algorithms refine these data but are generally expensive and time-consuming. In addition, the computation resource for the in silico docking approaches using DNA is still limited and challenging [ 145 , 146 , 147 ].…”
Section: Challenges and Limitationsmentioning
confidence: 99%
“…Some algorithms refine these data but are generally expensive and time-consuming. In addition, the computation resource for the in silico docking approaches using DNA is still limited and challenging [ 145 , 146 , 147 ].…”
Section: Challenges and Limitationsmentioning
confidence: 99%
“…Hepatotoxicity data from histopathology-related findings as originating from preclinical toxicity study reports for regulatory submissions can be collated into groups of histopathology terms related to similar findings (and, possibly, potential mechanisms); general clusters are identified: tissue damage, inflammatory changes, structural alteration, and accumulative lesions with each general cluster separating into more specific groups as shown in Table 2 [145]. The same hierarchical organization is applied to other target organs (i.e., heart and kidney) [16]. [124,133,[146][147][148], and other secondary mechanisms such as those linked to the disruption of the gut-liver axis [149].…”
Section: Processes and Endpointsmentioning
confidence: 99%
“…The present work focuses on hepatotoxicity and aims at building a robust and pragmatic framework upon which IST protocols for organ toxicity can then be established; toxicity to other major target organs (heart, kidney, lung and nervous system) is discussed elsewhere [16,17]. This manuscript outlines a series of potential applications of the protocols, then summarizes general concepts concerning the state-of-thescience and organization of knowledge related to organ toxicity, and reviews liver toxicity to provide context to the endpoints requiring prediction.…”
Section: Introductionmentioning
confidence: 99%
“…Predictive models for DICT could save considerable time, resources, and human suffering, with the ultimate goal of preventing adverse events in clinical trials and the postmarket stage. However, predicting any in vivo effect is not a trivial classification task, and most predictive models are built on proxy end points (which are often reduced to binary end points) without taking into account in vivo parameters such as pharmacokinetic parameters. , While no models for DICTrank have been publicly available yet to the best of our knowledge, various studies have predicted proxy in vitro assays or side effect data from side effects resource (SIDER), some of which are related to cardiotoxicity . Studies focusing on side effects and proxy targets (such as hERG) are reasonable given that compounds that have cardiac-related indications are more likely to show related side effects as well or activity on ion channels …”
Section: Introductionmentioning
confidence: 99%